CVS Health Corp (CVS) Financials

$96.74

$-0.46 (-0.47%)

As on 04-Sep-2026 16:15EDT

Market cap

$124,316 Mln

Revenue (TTM)

$415,086 Mln

P/E Ratio

25.6

P/B Ratio

1.6

Div. Yield

2.7 %

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Operating Revenue	415,086.00	402,067.00	372,809.00	357,776.00	322,467.00	292,111.00
Cost of Revenue	356,340.00	346,705.00	321,408.00	303,345.00	267,965.00	239,991.00
Gross Profit	58,746.00	55,362.00	51,401.00	54,431.00	54,502.00	52,120.00
Operating Expenses	50,458.00	44,977.00	42,885.00	39,832.00	46,548.00	38,810.00
Operating Profit (EBIT)	8,288.00	10,385.00	8,516.00	13,743.00	7,954.00	13,310.00
Other Income	--	--	--	--	169.00	-270.00
Profit before Tax	5,787.00	2,136.00	6,148.00	11,173.00	5,836.00	10,537.00
Provision for Tax	916.00	408.00	1,562.00	2,805.00	1,509.00	2,548.00
Profit after Tax (Net Income)	4,906.00	1,768.00	4,614.00	8,344.00	4,311.00	8,001.00
Minority Interest	5.00	40.00	28.00	-24.00	16.00	-12.00
Consolidated Profit	-1,032.00	1,768.00	4,614.00	8,344.00	4,149.00	7,910.00

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Shareholder's Funds	79,702.00	75,214.00	75,560.00	76,461.00	71,469.00	75,075.00
Minority Interest	5.00	--	--	--	300.00	306.00
Non-Current Liabilities	86,828.00	96,990.00	92,876.00	93,903.00	87,085.00	89,811.00
Current Liabilities	87,041.00	88,692.00	84,609.00	79,189.00	69,421.00	67,807.00
Total Liabilities	340,809.00	261,064.00	253,215.00	249,728.00	228,275.00	232,999.00

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Non-Current Assets	178,422.00	186,350.00	184,570.00	181,870.00	162,642.00	172,991.00
Current Assets	75,346.00	74,714.00	68,645.00	67,858.00	65,633.00	60,008.00
Total Assets	340,809.00	261,064.00	253,215.00	249,728.00	228,275.00	232,999.00
Total Debt*	76,306.00	93,593.00	82,920.00	79,385.00	70,732.00	75,999.00
Net Current Assets	-11,695.00	-13,978.00	-15,964.00	-11,331.00	-4,054.00	-7,799.00

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Cash From Operating Activities	--	10,639.00	9,107.00	13,426.00	16,177.00	18,265.00
Cash Flow from Investing Activities	--	-5,871.00	-7,613.00	-20,889.00	-5,047.00	-5,261.00
Cash from Financing Activities	--	-4,940.00	-1,135.00	2,683.00	-10,516.00	-11,356.00
Net Cash Inflow / Outflow	--	--	--	--	614.00	1,648.00

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Adjusted EPS ($)	3.81	1.38	3.66	6.45	3.27	5.99
Cash EPS ($)	3.79	4.99	7.30	9.83	6.49	9.37
Adjusted Book Value ($)	62.37	58.90	59.92	59.13	54.18	56.19
Dividend per Share ($)	2.74	--	--	--	--	--
Cash Flow per Share ($)	--	8.33	7.22	10.38	12.26	13.67
Free Cash Flow per Share ($)	--	6.11	5.02	8.04	10.20	11.79

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
ROCE (%)	--	1.08	2.94	5.60	2.94	5.24
ROE (%)	6.34	2.35	6.07	11.28	5.88	11.08
ROA (%)	1.42	0.69	1.83	3.49	1.87	3.45
EBIT Margin (%)	2.14	1.31	2.44	3.84	2.52	4.46
Net Margin (%)	1.18	0.44	1.24	2.33	1.34	2.74
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Revenue Growth (%)	7.36	0.08	0.04	0.11	0.10	0.09
EBIT Growth (%)	-6.91	-42.16	-33.89	69.19	-37.71	2.86
Net Profit Growth (%)	7.39	-61.68	-44.70	93.55	-46.12	11.45
EPS Growth (%)	6.23	-0.62	-0.43	0.97	-0.45	0.10
Book Value Growth (%)	1.96	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Price / Earnings	25.65	57.32	12.27	12.24	28.51	17.23
Price / Book Value	1.57	1.35	0.75	1.34	1.72	1.84
Dividend Yield (%)	2.74	--	--	--	--	--
EV/EBITDA	13.96	18.69	9.39	12.37	14.41	11.49
Close Price ($)	103.45	79.36	44.89	78.96	93.19	103.16
High Price ($)	106.15	85.15	83.25	93.45	111.25	104.56
Low Price ($)	58.50	44.11	43.56	64.41	86.28	68.02
Market Cap ($ Cr)	124,315.92	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debt to Equity	0.75	1.24	1.10	1.04	0.99	1.01
Short term debt to equity ratio	0.05	0.08	0.10	0.06	0.05	0.08
Current Ratio	0.87	0.84	0.81	0.86	0.95	0.88
Quick Ratio	0.66	0.63	0.60	0.63	0.67	0.62
Interest Coverage	2.87	1.68	3.07	5.17	3.55	5.21

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21
Debtors to sales (%)	9.71	9.89	9.78	9.85	8.46	8.36
Asset Turnover	1.20	1.56	1.48	1.50	1.40	1.26
Receivable days	--	34.63	35.12	31.90	29.28	28.87
Inventory Days	--	19.68	20.53	22.34	25.11	27.59
Payable days	--	39.65	17.49	17.90	18.66	18.02
Cash Conversion Cycle	--	14.66	38.16	36.35	35.74	38.44

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement ($ Mln)